Aflibercept with higher dose given at longer interval Promising in neovascular eye disease Dr. Kamal Kant Kohli4 Oct 2022 8:00 PM ISTAflibercept 8 mg is investigational, and its safety and efficacy have not been evaluated by any regulatory authority.According to two randomized...
Roche gets European Commission approval for Vision loss drug Vabysmo Ruchika Sharma20 Sept 2022 12:45 PM ISTBasel: Roche has announced that the European Commission (EC) has approved Vabysmo (faricimab) for the treatment of neovascular or 'wet' age-related...
Does subthreshold micropulse laser provide better outcomes in diabetic macular edema treatment? Jacinthlyn Sylvia15 Sept 2022 7:30 PM ISTUK: Subthreshold micropulse laser (SML) was similar to standard laser (SL) in binocular best-corrected visual acuity (BCVA), says an article published...
Suprachoroidal Triamcinolone Acetonide safe and effective for treatment of Diabetic Macular Edema Dr Ishan Kataria15 July 2022 8:00 PM ISTDiabetes mellitus (DM) is becoming a very important public health problem. Diabetic retinopathy (DR) is the most frequent and severe ocular...
CDSCO panel approves Allergan Dexamethasone Intravitreal Implant for Diabetic Macular Edema Dr. Divya Colin13 Jun 2022 6:00 PM ISTNew Delhi: Based on the justification provided by the drug-maker Allergan India, the Subject Expert Committee (SEC) functional under Central Drug...
Risk of visual acuity loss similar for eyes with diabetic macular edema initially treated vs observed Medha Baranwal21 April 2022 9:00 AM ISTAustralia: The risk of 5-letter visual acuity (VA) loss at 24 months was found to be similar between eyes with the clinically significant diabetic...
Fenofibrate Use Benefits Patients With Diabetic Retinopathy: JAMA MD Bureau15 April 2022 11:00 AM ISTThe association between fenofibrate and diabetic retinopathy (DR) has been studied extensively due to the high prevalence of DR in diabetic patients....
Brolucizumab improves visual outcomes in diabetic macular edema patients Medical Dialogues Editorial Team14 Feb 2022 9:00 AM ISTUSA: In patients with diabetic macular edema (DME), brolucizumab 6mg exhibited significant visual and anatomical improvements, as well as a favorable...
Intravitreal faricimab improves vision and retinal anatomy in diabetic macular edema cases: Lancet Medical Dialogues Editorial Team7 Feb 2022 9:00 AM ISTUSA: A team of researchers led by Charles C Wykoff conducted a study that showed that with flexible dosage up to every 16 weeks, faricimab showed...
Roche gets USFDA nod for injectable eye medicine Vabysmo Ruchika Sharma1 Feb 2022 1:37 PM ISTBasel: Roche has recently announced that the U.S. Food and Drug Administration (USFDA) has approved Vabysmo (faricimab-svoa) for the treatment of...
DEX implant predicts fluocinolone acetonide intravitreal implant outcome in diabetic macular edema patients: Study Medha Baranwal29 Jan 2022 9:00 AM ISTItaly: A recent study reported that a positive response to the dexamethasone (DEX) implant may be predictive of positive responses to the fluocinolone...
Aflibercept Improves Contrast sensitivity in Diabetic Macular Edema MD Bureau25 Jan 2022 9:00 AM ISTDiabetic macular edema (DME) is the most common cause of decreased best-corrected visual acuity (BCVA) and irreversible vision loss, with up to 10% of...
